首页> 外文期刊>Coronary artery disease >Hemodynamic responses and long-term follow-up results in patients using chronic beta 1-selective and nonselective beta-blockers during dobutamine stress echocardiography.
【24h】

Hemodynamic responses and long-term follow-up results in patients using chronic beta 1-selective and nonselective beta-blockers during dobutamine stress echocardiography.

机译:在多巴酚丁胺应激超声心动图检查期间使用慢性β1选择性和非选择性β受体阻滞剂的患者的血流动力学响应和长期随访结果。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: This study was undertaken to determine to what extent hemodynamic responses to dobutamine infusion between patients using concomitant beta1-selective or nonselective beta-blockers differ and whether this difference affects the long-term prognostic value of dobutamine stress echocardiography with respect to cardiac events. DESIGN: Single center, observational study. METHODS: A total of 1234 patients using chronic beta-blockers underwent dobutamine stress echocardiography and were prospectively included in the study. Heart rate and blood pressure responses were measured during the dobutamine stress echocardiography protocol. During a median follow-up time of 4 years (range: 0.5-14 years), overall and cardiac mortality and nonfatal myocardial infarction were noted. RESULTS: A total of 954 and 280 patients were using beta1-selective and nonselective beta-blockers, respectively. During dobutamine stress echocardiography, the heart rate response was significantly higher, systolic and diastolic blood pressure responses were significantly lower and the double product of heart rate and systolic blood pressure was similar in patients using beta1-selective than in patients using nonselective beta-blockers. In patients with and without new wall motion abnormalities during dobutamine stress echocardiography, a similar cardiac event-free survival was observed irrespective of the selectivity of beta-blockers (P=0.9 and 0.3, respectively). CONCLUSION: During dobutamine stress echocardiography, heart rate and blood pressure response was different, but the double product was similar in patients using beta1-selective or nonselective beta-blockers, which may explain why the long-term prognostic value of dobutamine stress echocardiography is similar in these two groups.
机译:目的:本研究旨在确定使用β1-选择性或非选择性β-受体阻滞剂的患者对多巴酚丁胺输注的血液动力学反应在多大程度上有所不同,以及这种差异是否影响多巴酚丁胺负荷超声心动图在心脏事件方面的长期预后价值。设计:单中心,观察性研究。方法:总共有1234名使用慢性β受体阻滞剂的患者接受了多巴酚丁胺负荷超声心动图检查,并有前瞻性纳入研究。在多巴酚丁胺应激超声心动图方案中测量心率和血压反应。在4年的中位随访时间(范围:0.5-14年)中,记录了总体和心脏死亡率以及非致命性心肌梗塞。结果:共有954和280例患者分别使用β1选择性和非选择性β受体阻滞剂。在多巴酚丁胺应激超声心动图检查期间,使用β1选择性患者的心率反应显着较高,收缩压和舒张压反应显着降低,并且心率和收缩压的两倍积与使用非选择性β受体阻滞剂的患者相似。在多巴酚丁胺应力超声心动图检查期间有和没有新的壁运动异常的患者中,无论β-受体阻滞剂的选择性如何(P分别为0.9和0.3),都观察到了相似的无心脏事件的生存期。结论:在多巴酚丁胺负荷超声心动图检查中,心率和血压反应不同,但使用β1选择性或非选择性β受体阻滞剂的患者的双重乘积相似,这可以解释为什么多巴酚丁胺负荷超声心动图的长期预后价值相似在这两组中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号